Equities

Maxigen Biotech Inc

1783:TAI

Maxigen Biotech Inc

Actions
  • Price (TWD)41.90
  • Today's Change0.05 / 0.12%
  • Shares traded123.00k
  • 1 Year change-10.85%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments433801540
Total Receivables, Net97100114
Total Inventory857579
Prepaid expenses4.661650
Other current assets, total0.080.890.26
Total current assets620993784
Property, plant & equipment, net430437465
Goodwill, net------
Intangibles, net0.491.161.83
Long term investments4338.838.86
Note receivable - long term------
Other long term assets0.180.212.21
Total assets1,4931,4481,265
LIABILITIES
Accounts payable173640
Accrued expenses655540
Notes payable/short-term debt000
Current portion long-term debt/capital leases--02.36
Other current liabilities, total506033
Total current liabilities131152116
Total long term debt007.28
Total debt009.64
Deferred income tax0.490.55--
Minority interest------
Other liabilities, total0.020.020.12
Total liabilities132152123
SHAREHOLDERS EQUITY
Common stock889847770
Additional paid-in capital296282264
Retained earnings (accumulated deficit)245170110
Treasury stock - common------
Unrealized gain (loss)(67)----
Other equity, total(2.46)(3.04)(2.96)
Total equity1,3611,2961,142
Total liabilities & shareholders' equity1,4931,4481,265
Total common shares outstanding898989
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.